DataMEDS AI, Inc. (MEDS) Stock Overview
Explore DataMEDS AI, Inc.’s financial performance, market position, analyst ratings, and future outlook.
DataMEDS AI, Inc. (MEDS)
Key Financials
Key Financials
Market Cap
3.6M
P/E Ratio
-0.03
EPS (TTM)
N/A
ROE
8.78%
MEDS Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of DataMEDS AI, Inc. (NASDAQ: MEDS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, DataMEDS AI, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of MEDS on the NASDAQ shows an RSI of 23.50, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind DataMEDS AI, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.03 and a market capitalization of 3.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of MEDS on the NASDAQ.